Safety and efficacy of pharmacologic weight loss in patients with cirrhosis.

Ali Y FakhreddineSamantha BagsicKen FujiokaCatherine T Frenette

Published in: Obesity science & practice (2020)

Pharmacologic weight loss in patients with advanced liver fibrosis appears feasible based on preliminary safety and efficacy outcomes in this study. Future prospective studies are warranted to evaluate a potential significant treatment gap in the management of obesity in this vulnerable population.

Keyphrases

weight loss
liver fibrosis
bariatric surgery
roux en y gastric bypass
gastric bypass
weight gain
metabolic syndrome
obese patients
insulin resistance
current status
human health
risk assessment
case control
body mass index
combination therapy
climate change